271
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging

, , , , , , & show all
Pages 652-666 | Received 22 Mar 2011, Accepted 23 Jun 2011, Published online: 22 Jul 2011

References

  • Albrecht T, Dawson P. 2000. Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878–882.
  • Altinoglu EI, Russin TJ, Kaiser JM, Barth BM, Eklund PC, Kester M, Adair JH. 2008. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2:2075–2084.
  • Ashokan A, Menon D, Nair S, Koyakutty M. 2010. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 31:2606–2616.
  • Barth BM, Sharma R, Altinoglu EI, Morgan TT, Shanmugavelandy SS, Kaiser JM, 2010. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 4:1279–1287.
  • Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. 2007. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 104:15549–15554.
  • Carr DH, Brown J, Bydder GM, Steiner RE, Weinmann HJ, Speck U, 1984. Gadolinium DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. Am J Roentgenol 143:215–224.
  • Choi JS, Jun YW, Yeon SI, Kim HC, Shin JS, Cheon J. 2006. Biocompatible heterostructured nanoparticles for multimodal biological detection. J Am Chem Soc 128:15982–15983.
  • Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, 2008. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 8:3715–3723.
  • Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11–18.
  • Devoisselle JM, Soulie-Begu S, Mordon S, Desmettre T, Maillols H. 1998. A preliminary study of the in vivo behavior of an emulsion formulation of indocyanine green. Laser Med Sci 13:279–282.
  • Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–495.
  • Dobrovolskaia MA, McNeil SE. 2007. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469–478.
  • Edward M, Quinn JA, Burden AD, Newton BB, Jardine AG. 2010. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Radiology 256:735–743.
  • Ersoy H, Rybicki FJ. 2007. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26:1190–1197.
  • Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, 2008. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 116:1607–1613.
  • Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. 2007. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 115:403–409.
  • Goldsby RA, Kindt TJ, Osborne BA, Kuby J. 2003. Immunology. 5th ed. New York: W.H. Freeman and company. pp 236.
  • Harboe M. 1959. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest 11:66–70.
  • Hope TA, Herfkens RJ, Denianke KS, LeBoit PE, Hung YY, Weil E. 2009. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol 44:135–139.
  • Jaffer FA, Libby P, Weissleder R. 2009. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol 29:1017–1024.
  • Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. 2003. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263–266.
  • John AE, Lukacs NW, Berlin AA, Palecanda A, Bargatze RF, Stoolman LM, Nagy JO. 2003. Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease. FASEB J 17:2296–2298.
  • Kester M, Heakal Y, Fox T, Sharma A, Robertson GP, Morgan TT, 2008. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 8:4116–4121.
  • Kim JS, Rieter WJ, Taylor KM, An H, Lin W, Lin W. 2007. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J Am Chem Soc 129:8962–8963.
  • Kim J, Lee JE, Lee SH, Yu JH, Lee JH, Park TG, Hyeon T. 2008. Designed Fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer- targeted imaging and magnetically guided drug delivery. Adv Mater 20:478–483.
  • Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. 2003. A multimodal nanoparticle for pre-operative magnetic resonance imaging and intra-operative optical brain tumor delineation. Cancer Res 63:8122–8125.
  • Lee JH, Jun YW, Yeon SI, Shin JS, Cheon J. 2006. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed Engl 45:8160–8162.
  • Li C, Penet MF, Winnard P Jr, Artemov D, Bhujwalla ZM. 2008. Image-guided enzyme/prodrug cancer therapy. Clin Cancer Res 14:515–522.
  • Malicka J, Gryczynski I, Geddes CD, Lakowicz JR. 2003. Metal-enhanced emission from indocyanine green: a new approach to in vivo imaging. J Biomed Opt 8:472–478.
  • Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. 2009. The role of nanoparticle size in hemocompatibility. Toxicology 258:139–147.
  • Miller VM, Hunter LW, Chu K, Kaul V, Squillace PD, Lieske JC, Jayachandran M. 2009. Biologic nanoparticles and platelet reactivity. Nanomedicine (Lond) 4:725–733.
  • Mondejar SP, Kovtun A, Epple M. 2007. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. J Mater Chem 17:4153–4159.
  • Moore A, Medarova Z, Potthast A, Dai G. 2004. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64:1821–1827.
  • Morgan TT, Muddana HS, Altinoglu EI, Rouse SM, Tabakovic A, Tabouillot T, 2008. Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett 8:4108–4115.
  • Mulder WJ, Koole R, Brandwijk RJ, Storm G, Chin PT, Strijkers GJ, 2006. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 6:1–6.
  • Pattani A, Patravale VB, Panicker L, Potdar PD. 2009. Immunological effects and membrane interactions of chitosan nanoparticles. Mol Pharm 6:345–352.
  • Pettibone JM, Dodd AA, Thorne PS, O'Shaughnessy PT, Weydert JA, Grassian VH. 2008. Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles. Nanotoxicology 2:189–204.
  • Philip R, Penzkofer A, Baumler W, Szeimies RM, Abels C. 1996. Absorption and fluorescence spectroscopic investigation of indocyanine green. J Photochem Photobiol A 96:137–148.
  • Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882–893.
  • Remy-Jardin M, Bahepar J, Lafitte JJ, Dequiedt P, Ertzbischoff O, Bruzzi J, 2006. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients. Radiology 238:1022–1035.
  • Rieter WJ, Kim JS, Taylor KM, An H, Lin W, Tarrant T, Lin W. 2007. Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed Engl 46:3680–3682.
  • Sahli H, Tapon-Bretaudiere J, Fischer AM, Sternberg C, Spenlehauer G, Verrecchia T, Labarre D. 1997. Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials 18:281–288.
  • Santra S, Bagwe RP, Dutta D, Stanley JT, Walter GA, Tan W, 2005. Synthesis and characterization of fluorescent, radio-Opaque, and paramagnetic silica nanoparticles for multimodal bioimaging applications. Adv Mater 17:2165–2169.
  • Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. 2009. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett 9:3312–3317.
  • Shaunak S, Thomas S, Gianasi E, Godwin A, Jones E, Teo I, 2004. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol 22:977–984.
  • Sinha D, Seaman FS, Walsh PN. 1987. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX. Biochemistry 26:3768–3775.
  • Sokolova VV, Radtke I, Heumann R, Epple M. 2006. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials 27:3147–3153.
  • Sokolova V, Kovtun A, Prymak O, Meyer-Zaika W, Kubareva EA, Romanova EA, 2007. Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing. J Mater Chem 17:721–727.
  • Strijkers GJ, Kluza E, Van Tilborg GA, van der Schaft DW, Griffioen AW, Mulder WJ, Nicolay K. 2010. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis 13:161–173.
  • Tavano R, Segat D, Reddi E, Kos J, Rojnik M, Kocbek P, 2010. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond) 5:881–896.
  • Tiwari DK, Jin T, Behari J. 2011. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods 21:13–24.
  • Vizard DL, Wood DO, Papineni RV, Feke GD, Orton SP, McLaughlin WE. 2010. Analytical radiography for planar radiographic images implemented with a multi-modal system. Comput Methods Programs Biomed 99:88–97.
  • Wang W, Xiong W, Zhu Y, Xu H, Yang X. 2010. Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J Biomed Mater Res B Appl Biomater 93:59–64.
  • Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. 2005. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23:1418–1423.
  • Woodard JR, Hilldore AJ, Lan SK, Park CJ, Morgan AW, Eurell JA, 2007. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 28:45–54.
  • Wu HC, Wang TW, Sun JS, Wang WH, Lin FH. 2007. A novel biomagnetic nanoparticle based on hydroxyapatite. Nanotechnology 18:165601.
  • Yu J, Yaseen MA, Anvari B, Wong MS. 2007. Synthesis of near-infrared-absorbing nanoparticle-assembled capsules. Chem Mater 19:1277–1284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.